Hims & Hers Health reported Q1 GAAP EPS of $0.40, missing estimates by $0.43, while revenue rose 3.8% Y Y to $608.1M, missing by $8.75M. Despite the miss, the company issued stronger than expected guidance, The black market for weight loss drugs is booming, with unapproved injections of experimental drugs flooding online platforms and raising serious health concerns. So called Reta Pens are rapidly gaining traction on social Zepbound: How It Works, How to Inject It, and Side Effects Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity New England Journal of Medicine FDA Zepbound shortage ends, impacts patients, compounding pharmacies